Dr. Ranya Habash
Digital Health Network of Experts
Food & Drug Administration (FDA)
Dr. Ranya Habash is a world-renowned eye surgeon with a unique background in the clinical, technical, and business sides of medicine. She was appointed to the FDA’s Digital Health Network of Experts and named to The Ophthalmologist Power List several times, including the top 50 stars in the world "who will lead ophthalmology over the next few decades and shape its future," and as one of the “most influential people in ophthalmology” worldwide. With experiences as the CEO of LifeLong Vision, a Visionary Innovation Mentor at Stanford University, and the Medical Director of Technology at
Bascom Palmer Eye Institute, her perspective is extraordinary.
Habash began her journey as Founder of HipaaChat and Chief Medical Officer of Everbridge, a publicly traded global
leader in critical communications. She has collaborated with companies like Apple, Amazon, and Verizon to modernize
communication for hospitals on a global scale. As a result, she was named by Becker’s Hospital Review as a Top
Healthcare Entrepreneur to Know. Her telehealth training and materials have been internationally embraced, and her
work was cited in U.S. Senate Committee hearings for telehealth expansion in all medical specialties.
Habash joined Microsoft’s healthcare team to lead a global machine learning initiative, delivering multi-disease retinal
algorithms to automate diagnosis and treatment of eye conditions. As program manager, she worked to build a global
collaborative network for data sharing and digital health collaboration. Her Microsoft experience set the stage for her
current role as Chair of artificial intelligence for AECOS Americas & Europe, and her latest work in developing a large-scale data network using predictive analytics for precision medicine. Most recently, Habash co-founded MetaMed, an extended reality healthcare company for immersive surgical education, training, and next-generation patient care. This remarkable background inspires her goals and the continued impact she hopes to make on healthcare.